当前位置： SCI文献检索 > CARDIOLOGY IN THE YOUNG期刊下所有文献 > Propofol as a bridge to extubation for high-risk children with congenital cardiac disease.

Propofol as a bridge to extubation for high-risk children with congenital cardiac disease.

Abstract：

BACKGROUND:Children with congenital cardiac defects may have associated chromosomal anomalies, airway compromise, and/or pulmonary hypertension, which can pose challenges to adequate sedation, weaning from mechanical ventilation, and successful extubation. Propofol, with its unique properties, may be used as a bridge to extubation in certain cardiac populations. MATERIALS AND METHODS:We retrospectively reviewed 0-17-year-old patients admitted to the Cardiac Intensive Care Unit between January, 2007 and September, 2008, who required mechanical ventilation and received a continuous infusion of propofol as a bridge to extubation. Medical charts were reviewed for demographics, associated comorbidities, as well as additional sedation medications and haemodynamic trends including vital signs and vasopressor support during the peri-infusion period. Successful extubation was defined as no re-intubation required for respiratory failure within 48 hours. Outcomes measured were successful extubation, evidence for propofol infusion syndrome, haemodynamic stability, and fluid and inotropic requirements. RESULTS:We included 11 patients for a total of 12 episodes. Propofol dose ranged from 0.4 to 5.6 milligram per kilogram per hour with an average infusion duration of 7 hours. All patients were successfully extubated, and none demonstrated worsening metabolic acidosis suggestive of the propofol infusion syndrome. All patients remained haemodynamically stable during the infusion with average heart rates and blood pressures remaining within age-appropriate ranges. One patient received additional fluid but no increase in vasopressors was needed. CONCLUSIONS:This study suggests that propofol infusions may allow for successful extubation in a certain population of children with congenital cardiac disease. Further studies are required to confirm whether propofol is an efficient and safe alternative in this setting.

journal_name

Cardiol Young

journal_title

Cardiology in the young

authors

Teng SN,Kaufman J,Czaja AS,Friesen RH,da Cruz EM

doi

10.1017/S1047951110001344

subject

Has Abstract

pub_date

2011-02-01 00:00:00

pages

46-51

issue

eissn

1047-9511

issn

1467-1107

pii

S1047951110001344

journal_volume

pub_type

杂志文章

在线工具

Propofol as a bridge to extubation for high-risk children with congenital cardiac disease.